Individuals with type 2 diabetes, who are resistant to insulin, have an excess blood glucose level, which they are now trying to reduce using a new class of diabetes drugs known as the gliflozins. These new drugs lower the ...
Apr 21, 2015
0
55
EPFL scientists have developed a new method that can accurately simulate the chemical modification of the protein behind Parkinson's disease. The technique, has opened a new way of understanding Parkinson's, and can be expanded ...
Apr 2, 2015
0
52
The elderly often complain about hearing difficulties, especially when several people are talking all at once. Researchers at the Max Planck Institute for Cognitive and Brain Sciences in Leipzig have discovered that the reason ...
Feb 4, 2015
0
97
In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is ...
Feb 2, 2015
0
9
Researchers from Plymouth University Peninsula Schools of Medicine and Dentistry have received funding from Alzheimer's charity BRACE for a pilot study to investigate the role of proteins in the development of dementia diseases ...
Dec 3, 2014
0
0
A new study from UCLA found that a drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson's disease in mice.
Oct 8, 2014
0
2
The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown. An enticing ...
Sep 29, 2014
0
0
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Sep 25, 2014
0
0
Alpha waves appear to be even more active and important than neuroscientist Ole Jensen (Radboud University) already thought. He postulates a new theory on how the alpha wave controls attention to visual signals. His theory ...
May 23, 2014
0
0
Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein ...
Aug 26, 2013
0
0
